miR-206 directly decreased the expression of glycolytic enhancer 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) and suppressed the proliferation of ovarian cancer cells [41]. Here, PFKFB3 is linked to ovarian carcinoma.